There is a real medical need of new diagnostic tools for the early recognition of invasive Candida infections. We exploited a rather simple and rapid redox methodology to construct a bispecific monoclonal antibody (bsmAb) that combines a monoclonal antibody (mAb) directed against 1,3-β-D-glucan, a well-known, pan-fungal diagnostic biomarker, with a mAb recognizing MP65, a major immunogenic mannoprotein secreted by C.albicans and other Candida species. The bsmAb (MP65/bglu mAb) was successfully produced and purified at high yields and proved to bind and reveal simultaneously, with high sensitivity, the β-glucan and MP65 antigens in both purified and native forms. The MP65/bglu mAb is the first bispecific antibody generated against a fungal microorganism and may prove useful for the concurrent detection of different and clinically significant Candida biomarkers in patient sera.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747543PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148714PLOS

Publication Analysis

Top Keywords

monoclonal antibody
12
bispecific monoclonal
8
β-glucan mp65
8
candida species
8
mp65/bglu mab
8
murine bispecific
4
antibody
4
antibody simultaneously
4
simultaneously recognizing
4
recognizing β-glucan
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!